
Omaxe (OMAXE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
5.4B
Gross Profit
-608.0M
-11.23%
Operating Income
-1.2B
-21.73%
Net Income
-1.5B
-27.47%
Balance Sheet Metrics
Total Assets
148.8B
Total Liabilities
150.7B
Shareholders Equity
-2.0B
Cash Flow Metrics
Revenue & Profitability Trend
Omaxe Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 15.6B | 15.9B | 7.3B | 5.0B | 4.2B |
Cost of Goods Sold | 20.1B | 17.9B | 8.7B | 5.6B | 4.7B |
Gross Profit | -4.5B | -2.0B | -1.4B | -529.5M | -500.9M |
Gross Margin % | -28.8% | -12.7% | -18.7% | -10.5% | -11.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 801.5M | 913.9M | 438.8M | 627.0M |
Other Operating Expenses | 1.3B | 321.2M | 353.4M | 149.3M | 47.9M |
Total Operating Expenses | 1.3B | 1.1B | 1.3B | 588.1M | 674.9M |
Operating Income | -6.4B | -3.8B | -3.4B | -908.6M | -1.6B |
Operating Margin % | -41.3% | -24.1% | -46.7% | -18.0% | -39.0% |
Non-Operating Items | |||||
Interest Income | - | 142.2M | 145.4M | 106.2M | 258.2M |
Interest Expense | 2.0B | 1.1B | 929.6M | 1.0B | 1.4B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -7.6B | -5.1B | -4.6B | -1.9B | -3.0B |
Income Tax | -786.2M | -1.0B | -1.1B | -327.3M | -694.3M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -6.9B | -4.1B | -3.5B | -1.6B | -2.4B |
Net Margin % | -43.9% | -25.5% | -48.1% | -32.0% | -55.6% |
Key Metrics | |||||
EBITDA | -5.3B | -3.4B | -2.8B | -464.6M | -971.6M |
EPS (Basic) | ₹-37.51 | ₹-22.01 | ₹-19.02 | ₹-8.72 | ₹-12.86 |
EPS (Diluted) | ₹-37.51 | ₹-22.01 | ₹-19.02 | ₹-8.72 | ₹-12.86 |
Basic Shares Outstanding | 182884564 | 182900540 | 182900540 | 182900540 | 182900540 |
Diluted Shares Outstanding | 182884564 | 182900540 | 182900540 | 182900540 | 182900540 |
Income Statement Trend
Omaxe Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.0B | 1.9B | 1.9B | 1.3B | 1.1B |
Short-term Investments | 7.9B | 1.1B | 946.1M | 16.3M | 9.4M |
Accounts Receivable | 3.1B | 3.6B | 3.8B | 3.8B | 3.9B |
Inventory | 110.0B | 105.1B | 104.3B | 92.7B | 85.9B |
Other Current Assets | 8.2B | 7.7B | 7.4B | 5.2B | 3.7B |
Total Current Assets | 132.6B | 124.6B | 123.0B | 107.3B | 98.9B |
Non-Current Assets | |||||
Property, Plant & Equipment | 5.3B | 5.2B | 467.0M | 797.0M | 1.2B |
Goodwill | 1.6B | 962.6M | 986.5M | 1.2B | 1.2B |
Intangible Assets | 2.5M | 4.2M | 5.5M | 1.1M | 1.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 87.2M | 113.9M | 131.9M | 137.3M | 18.7M |
Total Non-Current Assets | 16.2B | 13.6B | 12.6B | 11.8B | 11.5B |
Total Assets | 148.8B | 138.2B | 135.6B | 119.2B | 110.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 13.3B | 11.4B | 11.9B | 10.0B | 10.8B |
Short-term Debt | 2.6B | 2.7B | 3.3B | 5.2B | 2.1B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 113.4B | - | 88.7B | 71.5B | 3.7B |
Total Current Liabilities | 139.5B | 121.9B | 114.7B | 97.2B | 84.3B |
Non-Current Liabilities | |||||
Long-term Debt | 5.3B | 4.1B | 6.8B | 5.2B | 8.8B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 170.4M | - | 43.6M | 42.4M | 44.8M |
Total Non-Current Liabilities | 11.2B | 11.4B | 11.8B | 9.4B | 11.9B |
Total Liabilities | 150.7B | 133.3B | 126.5B | 106.6B | 96.2B |
Equity | |||||
Common Stock | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B |
Retained Earnings | - | -8.1B | -4.1B | -591.8M | 1.0B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | -2.0B | 4.9B | 9.1B | 12.6B | 14.2B |
Key Metrics | |||||
Total Debt | 8.0B | 6.8B | 10.1B | 10.4B | 10.9B |
Working Capital | -6.9B | 2.6B | 8.2B | 10.2B | 14.6B |
Balance Sheet Composition
Omaxe Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -7.6B | -5.1B | -4.6B | -1.9B | -3.0B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 450.4M | 2.7B | -10.9B | -8.2B | -4.3B |
Operating Cash Flow | -5.9B | -1.2B | -14.6B | -6.6B | -3.1B |
Investing Activities | |||||
Capital Expenditures | -80.7M | -22.4M | -83.8M | -15.9M | 38.5M |
Acquisitions | -115.5M | 100.0K | 200.0K | -1.3M | -600.0K |
Investment Purchases | - | -512.0M | -1.6B | -300.2M | -7.6M |
Investment Sales | 0 | 100.0K | 100.0K | 1.0M | 0 |
Investing Cash Flow | -1.2B | -534.2M | -1.7B | -316.4M | 22.7M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | -2.8M | -300.0K | -300.0K | -2.8M |
Debt Issuance | 3.3B | 6.2B | 5.5B | 714.7M | 1.7B |
Debt Repayment | -3.6B | -9.3B | -5.5B | -4.8B | -3.5B |
Financing Cash Flow | -263.1M | -3.1B | 20.4M | -4.1B | -1.8B |
Free Cash Flow | 9.8B | 9.7B | 4.5B | 7.7B | 5.6B |
Net Change in Cash | -7.3B | -4.8B | -16.2B | -11.0B | -4.8B |
Cash Flow Trend
Omaxe Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-2.45
Forward P/E
13.19
Price to Sales
1.12
PEG Ratio
13.19
Profitability Ratios
Profit Margin
-48.24%
Operating Margin
-62.66%
Return on Equity
349.57%
Return on Assets
-4.61%
Financial Health
Current Ratio
0.95
Debt to Equity
-4.06
Beta
-0.37
Per Share Data
EPS (TTM)
₹-37.51
Book Value per Share
₹-11.22
Revenue per Share
₹82.12
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
omaxe | 16.9B | -2.45 | - | 349.57% | -48.24% | -4.06 |
DLF | 1.9T | 41.50 | 4.37 | 10.26% | 47.97% | 9.64 |
Macrotech Developers | 1.2T | 41.50 | 6.09 | 15.70% | 20.32% | 35.04 |
Tarc | 48.0B | 454.74 | 4.60 | -22.16% | -144.33% | 187.30 |
Hubtown | 47.3B | 35.83 | 1.50 | 1.88% | 25.31% | 32.10 |
Marathon Nextgen | 42.8B | 15.24 | 2.74 | 15.51% | 37.49% | 46.60 |
Financial data is updated regularly. All figures are in the company's reporting currency.